Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-03-04 @ 2:55 PM
Study NCT ID:
NCT05100303
Status:
UNKNOWN
Last Update Posted:
2021-10-29
First Post:
2021-10-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML)
Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HE071-CSP-022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None